Validating Biomarkers & Use in Clinical Trials to Demonstrate Target Engagement & Eligibility Criteria for Enrollment

Time: 11:30 am
day: Day One


  • Investigating neurodegenerative and inflammatory biomarkers to evaluate treatment effects in ALS
  • Correlating research markers with clinical outcome and interpreting conflicting results
  • Utilizing a biomarker panel as enrollment criteria for a clinical trial